CymaBay Therapeutics, Inc.
2019 Q4 - 2023 Q4 (14 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2023 Q4 | 2/13/2024 | 2,099 | 0.0% | 88,882 | 12/31/2023 |
| 2023 Q3 | 11/14/2023 | 1,411 | 0.0% | 94,613 | 9/30/2023 |
| 2023 Q2 | 8/21/2023 | 1,060 | 0.0% | 96,825 | 6/30/2023 |
| 2023 Q1 | 5/9/2023 | 649 | 0.0% | 74,391 | 3/31/2023 |
| 2022 Q1 | 5/16/2022 | 111 | 0.0% | 35,601 | 3/31/2022 |
| 2021 Q4 | 2/15/2022 | 129 | 0.0% | 38,109 | 12/31/2021 |
| 2021 Q3 | 11/15/2021 | 136 | 0.0% | 37,301 | 9/30/2021 |
| 2021 Q2 | 8/16/2021 | 417 | 0.0% | 95,709 | 6/30/2021 |
| 2021 Q1 | 5/18/2021 | 474 | 0.0% | 104,450 | 3/31/2021 |
| 2020 Q4 | 2/16/2021 | 602 | 0.0% | 104,923 | 12/31/2020 |
| 2020 Q3 | 11/17/2020 | 760 | 0.0% | 104,923 | 9/30/2020 |
| 2020 Q2 | 8/17/2020 | 366 | 0.0% | 104,923 | 6/30/2020 |
| 2020 Q1 | 5/13/2020 | 147 | 0.0% | 99,290 | 3/31/2020 |
| 2019 Q4 | 2/14/2020 | 217 | 0.0% | 110,967 | 12/31/2019 |